(Q43209670)

16 November 2017

C-reactive protein and cardiovascular risk: more fuel to the fire (English)

1 reference

16 November 2017

2

John J P Kastelein

1 reference

16 November 2017

S Matthijs Boekholdt

1

1 reference

PubMed ID

20031200

16 November 2017

language of work or name

English

0 references

publication date

22 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

375

1 reference

16 November 2017

9709

1 reference

16 November 2017

95-96

1 reference

Inflammation in atherosclerosis

16 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

C-reactive protein and atherogenesis: from fatty streak to clinical event

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Insight into the nature of the CRP-coronary event association using Mendelian randomization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962098-5

7 January 2021

10.1016/S0140-6736(09)62098-5

Identifiers

DOI

1 reference

16 November 2017

1 reference

PubMed ID

20031200